Purpose: Numerous studies of circulating epithelial cells (CECs) have been described in
cancer patients, and genetic abnormalities have been well documented. However, with one …

Several methodologies exist to enumerate circulating tumor cells (CTCs) from the blood of
cancer patients; however, most methodologies lack high‐resolution imaging, and thus, little …

In colorectal cancer (CRC), a proportion of patients with early stage disease still die of
metastatic or recurrent disease within 5 years of “curative” resection. Detection of carcinoma …

The detailed cytomorphologic appearance of circulating tumor cells (CTCs) in cancer
patients is not well described, despite publication of multiple methods for enumerating these …

Novel assay methods developed for the isolation and characterization of circulating tumor
cells (CTC) of epithelial origin offer the potential of markers for the non-invasive gathering of …

The aim of this study was the detection of circulating tumor cells (CTC) in three tumor types
of epithelial origin. Patients and Methods: Four hundred and thirty-eight patients with breast …

More than 90% of cancer deaths result from the development of hematogenously
disseminated metastasis. The presence of circulating tumor cells (CTCs) in patients with …

The objectives of this study were to assess whether the use of two reverse transcription-PCR
(RT-PCR) cDNA assays and multiple blood sampling increased circulating tumor cell …

Background: The circulating tumor cells of solid tumors, especially in colorectal cancer has
been of great interest in medical research in the last and new century. Methods: A literature …

The main focus of the study was to detect circulating tumor cells (CTCs) in ovarian cancer
(OC) patients using a new methodological approach (MetaCell TM) which is based on size …